The global hemodialysis vascular grafts market size is
expected to reach USD 276.5 million by 2025, according to a new report by Grand
View Research, Inc., progressing at a CAGR of 4.1% during the forecast period.
Increasing number of patients suffering from chronic kidney diseases (CKD) and
growing adoption of biological access products due to technological
advancements in the field are some of the factors contributing to revenue
growth. Higher number of renal impaired patients and limited availability of
suitable kidney donors are promoting hemodialysis procedures in renal impaired
patients, which in turn is expected to fuel the demand for vascular grafts over
the forecast period.
The global hemodialysis vascular graft
market, by raw material, was dominated by PTFE grafts with a revenue share of
45.0% in 2018. The segment is anticipated to maintain its position throughout
the forecast period. High product penetration, wide availability, and
comparatively cheaper products are supplementing the dominance of the segment.
Moreover, recent development of biological grafts for hemodialysis is expected
to increase its adoption, owing to lower possibility of rejection and infection
of these products.
North America dominated the market in
2018 and accounted for approximately 32.0% of the overall revenue. The U.S. is
a key revenue contributor not only in the region but at the global marketplace
as well. The growth of the market in the country can be attributed to growing
number of renal impaired patients undergoing hemodialysis and surging demand
for AVGs required to create superficial access for blood transfusion.
Developing economies such as China and
India have lower availability of kidney donors as compared to developed
economies. Thus patients opt for alternatives such as hemodialysis. Increase in
number of hemodialysis procedures is expected to drive the market between 2018
and 2025. Asia Pacific is poised to exhibit a CAGR of 6.6% between 2018 and
2025, owing to increasing number of patients with CKD, growing awareness
regarding safety of AVG, and rising healthcare expenditure.
Browse full research report on Hemodialysis Vascular Grafts Market: https://www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market
Further Key Findings From the Report Suggest:
- North America dominated the market in 2017, owing to
geightened awareness regarding treatment options available, increasing
adoption of hemodialysis access grafts, and technological advancements in
AVG
- Asia Pacific is anticipated to be the fastest growing
regional hemodialysis vascular graft market with a CAGR of 6.6 % between
2018 and 2025
- Some of the key market players in this market are W.L. Gore
& Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre
Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.;
CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics,
Inc.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market/request/rs1
Grand View Research has segmented the global hemodialysis vascular
graft market on the basis of raw material types, and region:
Hemodialysis Vascular Grafts Raw Material Outlook (Revenue, USD
Million, 2014 - 2025)
- Polyester
- Polytetrafluoroethylene
- Polyurethane
- Biological
Materials
Hemodialysis Vascular Grafts Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
No comments:
Post a Comment